Neurokinin-1 Receptor Antagonists
"Neurokinin-1 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS.
| Descriptor ID |
D064729
|
| MeSH Number(s) |
D27.505.519.625.487 D27.505.696.577.487
|
| Concept/Terms |
Neurokinin-1 Receptor Antagonists- Neurokinin-1 Receptor Antagonists
- Antagonists, Neurokinin-1 Receptor
- Neurokinin 1 Receptor Antagonists
- Receptor Antagonists, Neurokinin-1
- Neuroleukin-1 Receptor Blockers
- Blockers, Neuroleukin-1 Receptor
- Neuroleukin 1 Receptor Blockers
- Receptor Blockers, Neuroleukin-1
- Substance P Receptor Antagonists
- Tachykinin Receptor 1 Antagonists
- Tachykinin Receptor 1 Blockers
- Neurokinin-1 Receptor Blockers
- Blockers, Neurokinin-1 Receptor
- Neurokinin 1 Receptor Blockers
- Receptor Blockers, Neurokinin-1
- Substance P Receptor Blockers
|
Below are MeSH descriptors whose meaning is more general than "Neurokinin-1 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Neurokinin-1 Receptor Antagonists".
This graph shows the total number of publications written about "Neurokinin-1 Receptor Antagonists" by people in this website by year, and whether "Neurokinin-1 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Neurokinin-1 Receptor Antagonists" by people in Profiles.
-
Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-?B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 10; 103:105-114.
-
Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist. Psychopharmacology (Berl). 2018 Oct; 235(10):2847-2857.
-
Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitant. Anticancer Drugs. 2018 03; 29(3):243-252.
-
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2018 Apr; 124:21-28.
-
Meta-analysis of safety and efficacy of rolapitant, NK-1 receptor antagonist for prevention of chemotherapy-induced nausea and vomiting. Curr Probl Cancer. 2018 Mar - Apr; 42(2):241-255.
-
Findings on alcohol dependence point to promising avenues for targeted therapies. JAMA. 2009 Apr 22; 301(16):1643-5.
-
Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting. Expert Opin Pharmacother. 2007 Dec; 8(18):3217-35.
-
Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol. 2005 Apr; 288(4):L761-70.
-
Effects of neurokinins on airway and alveolar eosinophil recruitment. Exp Lung Res. 2003 Apr-May; 29(3):165-77.